Kennedy Trust renews commitment to rheumatology research with £20M
The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of £20M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.
Read moreKey link discovered between tissue cell type and different forms of arthritis
Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.
Read moreShowcasing a new approach to arthritis research
A recent workshop at Pembroke College, Oxford, provided a showcase for research within the Arthritis Therapy Acceleration Programme (A-TAP) aimed at speeding up the delivery of new drugs for immune-mediated inflammatory disease (IMIDs).
Read moreKennedy Institute of Rheumatology
A world-leading medical research centre where discovery research drives the development of transformative therapies for chronic inflammatory and degenerative disease.
240 Staff, students and academic visitors
30 Nationalities
£70M+ in Research Income
Select Publications
-
Angiocrine signals regulate quiescence and therapy resistance in bone metastasis
Singh A. et al, (2019), JCI Insight, 4
-
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Nayar S. et al, (2019), Proc Natl Acad Sci U S A, 116, 13490 - 13497
-
Distinct fibroblast subsets drive inflammation and damage in arthritis.
Croft AP. et al, (2019), Nature
-
The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis.
Mintz MA. et al, (2019), Immunity
Latest news
Bringing patients closer to arthritis research
8 July 2019